Franklin Resources’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Other funds holding PACB
AIM
NAMA
Franklin Resources's PACB Position: Q4 2025 in Review
Franklin Resources sold out of Pacific Biosciences (PACB) in Q4 2025, closing a stake of 14,223 shares — an estimated $18.2K sold.
Franklin Resources first reported a position in PACB in Q4 2020 and held it in 15 quarters. The position peaked at $1.03M in Q3 2021. 215 funds tracked by Wall St. Rank hold PACB as of Q4 2025.
- Franklin Resources reported no remaining Pacific Biosciences position as of Q4 2025 after selling out during the quarter.
- Franklin Resources sold 14,223 Pacific Biosciences shares in Q4 2025, an estimated $18.2K.
- Franklin Resources first reported a position in Pacific Biosciences in Q4 2020 and held it in 15 quarters.
- Franklin Resources's Pacific Biosciences position peaked at $1.03M in Q3 2021.
- 215 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2025.
Based on Franklin Resources's 13F filing for Q4 2025, filed 11 Feb 2026.